The present invention relates to a method of treating a disease or disorder characterised by increased stress hormone levels and/or decreased androgen hormone levels in a subject, comprising administering to the subject a therapeutically effective amount of a compound represented by formula (I): wherein n is 1 or 3 R is hydrogen or -C(O)N(Ra)(Rb) wherein Ra and Rb are independently -(C1-C4)alkyl, or -(C1-C4)alkyl-(C5-C7)aryl, wherein each of Ra and Rb is optionally substituted by -(C1-C4)alkoxy R1, R2, and R3, are independently hydrogen, halogen, cyano or -(C6-C10) aryl, wherein said -(C6-C10)aryl is optionally substituted by halogen, with the proviso that no more than one of R1, R2, and R3 is hydrogen and R4 and R5 are hydrogen or a pharmaceutically acceptable salt thereof.
